Fig. 2.
Countries where meningococcal B (MenB) vaccination in infants is routinely recommended nationwide (n = 14). For each country, the year of Bexsero® approval and the year of policy introduction are summarized, along with the recommended schedule and information on whether this vaccine is funded (i.e. provided free of charge) or provided for a fee. All data shown in this figure were obtained from publicly available country policy documents and/or from experts in the field.